Jump Financial, LLC Mirati Therapeutics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$27.8 - $45.35 $1.13 Million - $1.84 Million	40,667 New	40,667 $1.77 Million
Q3 2023 Nov 07, 2023	BUY	$27.8 - $45.35 $1.13 Million - $1.84 Million	40,667 New	40,667 $1.77 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $1.17 Million - $2.8 Million	28,422 New	28,422 $1.29 Million
Q2 2022 Aug 09, 2022	SELL	$39.16 - $88.71 $1.58 Million - $3.59 Million	-40,453 Reduced 91.48%	3,768 $253,000
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $3.35 Million - $6.68 Million	44,221 New	44,221 $3.64 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.